Influence of the diketonato ligand on the cytotoxicities of [Ru(eta(6)-p-cymene)-(R(2)acac)(PTA)](+) complexes (PTA=1,3,5-triaza-7-phosphaadamantane)

Details

Serval ID
serval:BIB_DA85235D88E7
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Influence of the diketonato ligand on the cytotoxicities of [Ru(eta(6)-p-cymene)-(R(2)acac)(PTA)](+) complexes (PTA=1,3,5-triaza-7-phosphaadamantane)
Journal
European Journal of Inorganic Chemistry
Author(s)
Vock  Carsten A., Renfrew  Anna K., Scopelliti.R , Lucienne.J-J , Paul J.D
ISSN
1434-1948
Publication state
Published
Issued date
2008
Peer-reviewed
Oui
Number
10
Pages
1661-1671
Language
english
Abstract
A series of compounds of general formula [Ru(eta(6)-p-cymene) (R(2)acac)(PTA)][X] (R(2)acac = Me(2)acac, tBu(2)acac, Ph(2)acac, Me(2)acac-Cl; PTA = 1,3,5-triaza-7-phosphaadamantane; X = BPh4, BF4), and the precursor to the Me2acac-Cl derivative [Ru(eta(6)-p-cymene)(Me(2)acac-Cl)Cl], have been prepared and characterised spectroscopically. Five of the compounds have also been characterised in the solid state by X-ray crystallography. The tetrafluoroborate salts are water-soluble, quite resistant to hydrolysis, and have been evaluated for cytotoxicity against A549 lung carcinoma and A2780 human ovarian cancer cells. The compounds are cytotoxic towards the latter cell line, and relative activities are discussed in terms of hydrolysis (less important) and lipophilicity, which appears to exert the dominating influence.
Keywords
bioorganometallics, anticancer drugs, metal-based drugs, ruthenium, X-ray structure, Ruthenium(Ii)-Arene Pta Complexes, Arene Complexes, Metal-Complexes, In-Vitro, Anticancer Drugs, Antitumor Drugs, Chemistry, Agents, Chemotherapy, Hydrolysis
Web of science
Create date
13/10/2009 14:58
Last modification date
20/08/2019 16:59
Usage data